Point-of-care Testing (POCT) for Chronic Disease Market Report： the global market size is projected to grow from USD 1136 million in 2023 to USD 1689 million by 2029

Point-of-Care Testing (POCT) refers to the technology of using testing equipment to conduct rapid, on-site detection of biomarkers related to chronic diseases in a non-laboratory environment of a medical institution.This type of test can usually give preliminary results in a short period of time (a few minutes to tens of minutes), allowing doctors to make timely diagnosis and treatment decisions or to help patients self-manage their diseases. The application of chronic disease POCT covers the screening, monitoring and management of many common chronic diseases such as diabetes, hypertension, heart disease, kidney disease, etc., providing great convenience and timeliness for medical services.

According to the new market research report "Point-of-care Testing (POCT) for Chronic Disease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030", published by QYResearch, the global Point-of-care Testing (POCT) for Chronic Disease market size is projected to grow from USD 1136 million in 2023 to USD 1689 million by 2029, at a CAGR of 6.83% during the forecast period.

 

• Global Point-of-care Testing (POCT) for Chronic Disease MarketSize(US$ Million), 2023-2029

 

Source: QYResearch, "Point-of-care Testing (POCT) for Chronic Disease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030”

 

 

 

• Global Point-of-care Testing (POCT) for Chronic Disease Top10 Players Rankingand Market Share (Ranking is based on the revenue of 2022, continually updated)

 

Source: QYResearch, "Point-of-care Testing (POCT) for Chronic Disease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030”

This report profiles key players of Point-of-care Testing (POCT) for Chronic Disease such as Abbott，BioMerieux，Siemens Healthineers，Roche，Danaher，Bio-Rad Laboratories

In 2022, the global top five Point-of-care Testing (POCT) for Chronic Disease players account for 38.65% of market share in terms of revenue. Above figure shows the key players ranked by revenue in Point-of-care Testing (POCT) for Chronic Disease.

• Point-of-care Testing (POCT) for Chronic Disease,Global Market Size, Split by ApplicationSegment

 

Source: QYResearch, "Point-of-care Testing (POCT) for Chronic Disease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030”

 

In terms of product application, Hospital is the largest application, hold a share of 65.38%,

 

Market Drivers:

1. Technological progress and innovation: The continuous development of portable testing equipment and kit technology has continuously improved the accuracy and sensitivity of POCT testing, making it easy and fast to operate, making it possible to conduct on-site testing of chronic diseases.
2. Growth in demand: With the aging of the population and changes in lifestyle, the base of patients with chronic diseases continues to expand, and the demand for early diagnosis and daily monitoring has increased significantly, promoting the widespread application of POCT in the management of chronic diseases.
3. Uneven distribution of medical resources: Especially in remote areas and primary medical institutions, due to limited laboratory testing resources, POCT technology can make up for this gap, improve the level of primary medical care and move forward disease prevention and control.
4. Policy support and medical insurance coverage: The government’s increase in public health investment and the inclusion of some chronic disease POCT projects in the scope of medical insurance reimbursement have greatly stimulated the promotion and use of POCT in chronic disease management.
5. Patient self-management needs: With the change in health concepts, patients pay more attention to disease self-management. Home POCT equipment can facilitate patients to monitor blood sugar, blood pressure and other indicators at home, meeting the needs of individualized health management.

Restraint:

1. Technical limitations: Although POCT technology has made significant progress, the detection accuracy and stability of some complex biochemical indicators are still not as good as those of large laboratory instruments, which may lead to misdiagnosis or missed diagnosis.
2. High cost: The production cost of some POCT equipment and kits is high, resulting in high selling prices. Coupled with the increase in testing frequency, it may increase the financial burden on patients.
3. Quality supervision and standardization issues: Since POCT equipment is scattered in various medical points and households, how to ensure the consistency and accuracy of test results and establish a unified quality control system is a major challenge currently faced.
4. Insufficient doctor-patient education and awareness: Doctors and patients have varying understandings of how to use POCT, interpret results, and integrate it with clinical decision-making, which may affect the widespread application of POCT.
5. Data interconnection and privacy protection: How to effectively integrate the large amount of test data generated by POCT into the electronic medical record system, and how to ensure the security of personal privacy during the data transmission and sharing process, are issues that need to be solved urgently.

About The Authors

Yaping Zhao - Lead Author

Email: zhaoyaping@qyresearch.com

About QYResearch

QYResearch founded in California, USA in 2007.It is a leading global market research and consulting company. With over 16 years’ experience and professional research team in various cities over the world QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 60,000 clients across five continents. Let’s work closely with you and build a bold and better future.

QYResearch is a world-renowned large-scale consulting company. The industry covers various high-tech industry chain market segments, spanning the semiconductor industry chain (semiconductor equipment and parts, semiconductor materials, ICs, Foundry, packaging and testing, discrete devices, sensors, optoelectronic devices), photovoltaic industry chain (equipment, cells, modules, auxiliary material brackets, inverters, power station terminals), new energy automobile industry chain (batteries and materials, auto parts, batteries, motors, electronic control, automotive semiconductors, etc.), communication industry chain (communication system equipment, terminal equipment, electronic components, RF front-end, optical modules, 4G/5G/6G, broadband, IoT, digital economy, AI), advanced materials industry Chain (metal materials, polymer materials, ceramic materials, nano materials, etc.), machinery manufacturing industry chain (CNC machine tools, construction machinery, electrical machinery, 3C automation, industrial robots, lasers, industrial control, drones), food, beverages and pharmaceuticals, medical equipment, agriculture, etc.

 

Contact Us:

If you have any queries regarding this report or if you would like further information, please contact us:

QY Research Inc.

Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States

E-mail: global@qyresearch.com

Tel: 001-626-842-1666(US)  0086-133 1872 9947(CN)

EN: https://www.qyresearch.com

JP: https://www.qyresearch.co.jp